Cytogen Broadens Oncology MRI Agent Portfolio Via Advanced Magnetics
This article was originally published in The Gray Sheet
Executive Summary
Cytogen's acquisition of magnetic resonance imaging agent developer Advanced Magnetics will expand Cytogen's oncology imaging agent franchise and strengthen its position in "cancer staging and detection," the firm says. The definitive, stock-for-stock acquisition agreement, announced July 10, is valued at approximately $60 mil.